{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:10:56Z","timestamp":1772165456914,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug repurposing aims to detect the new therapeutic benefits of the existing drugs and reduce the spent time and cost of the drug development projects. The synthetic repurposing of drugs may prove to be more useful than the single repurposing in terms of reducing toxicity and enhancing efficacy. However, the researchers have not given it serious consideration. To address the issue, a novel datamining method is introduced and applied to repositioning of drugs for hypertension (HT) which is a serious medical condition and needs some improved treatment plans to help treat it.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A novel two-step data mining method, which is based on the If-Then association rules as well as a novel discrete optimization algorithm, was introduced and applied to the synthetic repurposing of drugs for HT. The required data were also extracted from DrugBank, KEGG, and DrugR+ databases. The findings indicated that based on the different statistical criteria, the proposed method outperformed the other state-of-the-art approaches. In contrast to the previously proposed methods which had failed to discover a list on some datasets, our method could find a combination list for all of them.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Since the proposed synthetic method uses medications in small dosages, it might revive some failed drug development projects and put forward a suitable plan for treating different diseases such as COVID-19 and HT. It is also worth noting that applying efficient computational methods helps to produce better results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12859-020-03644-w","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T05:02:46Z","timestamp":1594875766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm"],"prefix":"10.1186","volume":"21","author":[{"given":"Yosef","family":"Masoudi-Sobhanzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Masoudi-Nejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"3644_CR1","doi-asserted-by":"crossref","unstructured":"Kaszuba AM, Konior A, Mikolajczyk T, Prejbisz A, Kabat M, Januszewicz A, et al. P2629T cell subset imbalance in hypertension is not associated with angiotensin II levels in patients with primary and secondary hypertension. Eur Heart J. 2017;38(suppl_1).","DOI":"10.1093\/eurheartj\/ehx502.P2629"},{"key":"3644_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/HYPERTENSIONAHA.119.13818","volume":"75","author":"R Bigazzi","year":"2020","unstructured":"Bigazzi R, Zagato L, Lanzani C, Fontana S, Messaggio E, Delli Carpini S, et al. Hypertension in high school students: genetic and environmental factors: the HYGEF study. Hypertension. 2020;75:71\u20138.","journal-title":"Hypertension"},{"key":"3644_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","volume":"71","author":"RJ Johnson","year":"2018","unstructured":"Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, et al. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. Am J Kidney Dis. 2018;71:851\u201365.","journal-title":"Am J Kidney Dis"},{"key":"3644_CR4","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/j.respe.2018.05.072","volume":"66","author":"V Walker","year":"2018","unstructured":"Walker V, Davies N, Kehoe P, Martin R. Can treatments for hypertension be repurposed for the treatment of dementia? Rev Epidemiol Sante Publique. 2018;66:S262.","journal-title":"Rev Epidemiol Sante Publique"},{"key":"3644_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.chest.2017.12.008","volume":"154","author":"C Khouri","year":"2018","unstructured":"Khouri C, Lepelley M, Roustit M, Montastruc F, Humbert M, Cracowski J-L. Comparative safety of drugs targeting the nitric oxide pathway in pulmonary hypertension: a mixed approach combining a meta-analysis of clinical trials and a disproportionality analysis from the world health organization pharmacovigilance database. Chest. 2018;154:136\u201347.","journal-title":"Chest"},{"key":"3644_CR6","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.118.11916","volume":"73","author":"R Zack","year":"2019","unstructured":"Zack R, Okunade O, Olson E, Salt M, Amodeo C, Anchala R, et al. Improving hypertension outcome measurement in low-and middle-income countries. Hypertension. 2019;73:990\u20137.","journal-title":"Hypertension"},{"issue":"Suppl_1","key":"3644_CR7","first-page":"A14286","volume":"140","author":"S Saluja","year":"2019","unstructured":"Saluja S, Jiang X, Finan C, Chopade S, Eales J, Xu X, et al. New drug repurposing opportunities for hypertension uncovered by the convergence of genomics with kidney transcriptomics and epigenomics. Circulation. 2019;140(Suppl_1):A14286.","journal-title":"Circulation"},{"key":"3644_CR8","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","volume":"21","author":"W Sun","year":"2016","unstructured":"Sun W, Sanderson PE, Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discov Today. 2016;21:1189\u201395.","journal-title":"Drug Discov Today"},{"key":"3644_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ajg.2017.21","volume":"112","author":"K Papamichael","year":"2017","unstructured":"Papamichael K, Cheifetz AS. Therapeutic drug monitoring in IBD: the new standard-of-care for anti-TNF therapy. Am J Gastroenterol. 2017;112:673\u20136.","journal-title":"Am J Gastroenterol"},{"key":"3644_CR10","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2015-675","volume-title":"Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia","author":"BM Kuenzi","year":"2015","unstructured":"Kuenzi BM, Rix LLR, Kunigal SS, Kinose F, Knezevic CE, Wright G, et al. Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia. 2015."},{"key":"3644_CR11","volume-title":"MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy","author":"AM Kloxin","year":"2015","unstructured":"Kloxin AM, Mitra A, Shi VY, Cheng MY, Maverakis E, Ogawa H, et al. MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy. 2015."},{"key":"3644_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10853-018-2843-x","volume":"54","author":"RS Ullah","year":"2019","unstructured":"Ullah RS, Wang L, Yu H, Haroon M, Elshaarani T, Fahad S, et al. Synthesis of polyphosphazene and preparation of microspheres from polyphosphazene blends with PMMA for drug combination therapy. J Mater Sci. 2019;54:745\u201364.","journal-title":"J Mater Sci"},{"key":"3644_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45814-8","volume":"9","author":"Y Masoudi-Sobhanzadeh","year":"2019","unstructured":"Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M, Masoudi-Nejad A. Trader as a new optimization algorithm predicts drug-target interactions efficiently. Sci Rep. 2019;9:1\u201314.","journal-title":"Sci Rep"},{"key":"3644_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41563-019-0338-z","volume":"18","author":"S Ekins","year":"2019","unstructured":"Ekins S, Puhl AC, Zorn KM, Lane TR, Russo DP, Klein JJ, et al. Exploiting machine learning for end-to-end drug discovery and development. Nat Mater. 2019;18:435.","journal-title":"Nat Mater"},{"key":"3644_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18:463\u201377.","journal-title":"Nat Rev Drug Discov"},{"key":"3644_CR16","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1021\/acs.jcim.9b00626","volume":"59","author":"K Abbasi","year":"2019","unstructured":"Abbasi K, Poso A, Ghasemi J, Amanlou M, Masoudi-Nejad A. Deep transferable compound representation across domains and tasks for low data drug discovery. J Chem Inf Model. 2019;59:4528\u201339.","journal-title":"J Chem Inf Model"},{"key":"3644_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/1574893612666170707095707","volume":"13","author":"L Peng","year":"2018","unstructured":"Peng L, Peng M, Liao B, Huang G, Li W, Xie D. The advances and challenges of deep learning application in biological big data processing. Curr Bioinforma. 2018;13:352\u20139.","journal-title":"Curr Bioinforma"},{"key":"3644_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-019-2932-0","volume":"20","author":"M AlQuraishi","year":"2019","unstructured":"AlQuraishi M. ProteinNet: a standardized data set for machine learning of protein structure. BMC Bioinformatics. 2019;20:1\u201310.","journal-title":"BMC Bioinformatics"},{"key":"3644_CR19","doi-asserted-by":"crossref","unstructured":"Abbasi K, Razzaghi P, Poso A, Amanlou M, Ghasemi JB, Masoudi-Nejad A. DeepCDA: deep cross-domain compound-protein affinity prediction through LSTM and convolutional neural networks. Bioinformatics. 2020.","DOI":"10.1093\/bioinformatics\/btaa544"},{"key":"3644_CR20","first-page":"785","volume":"12","author":"L Carrara","year":"2017","unstructured":"Carrara L, Lavezzi SM, Borella E, De Nicolao G, Magni P, Poggesi I. Current mathematical models for cancer drug discovery. Expert Opin Drug Discov. 2017;12:785\u201399.","journal-title":"Expert Opin Drug Discov"},{"key":"3644_CR21","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.ygeno.2020.02.013","volume":"112","author":"M Torkamanian-Afshar","year":"2020","unstructured":"Torkamanian-Afshar M, Lanjanian H, Nematzadeh S, Tabarzad M, Najafi A, Kiani F, et al. RPINBASE: an online toolbox to extract features for predicting RNA-protein interactions. Genomics. 2020;112:2623\u201332.","journal-title":"Genomics"},{"key":"3644_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jep.2018.07.008","volume":"236","author":"P Wang","year":"2019","unstructured":"Wang P, Li K, Tao Y, Li D, Zhang Y, Xu H, et al. TCM-ADMEpred: a novel strategy for poly-pharmacokinetics prediction of traditional Chinese medicine based on single constituent pharmacokinetics, structural similarity, and mathematical modeling. J Ethnopharmacol. 2019;236:277\u201387.","journal-title":"J Ethnopharmacol"},{"key":"3644_CR23","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/bioinformatics\/btw342","volume":"32","author":"D Sridhar","year":"2016","unstructured":"Sridhar D, Fakhraei S, Getoor L. A probabilistic approach for collective similarity-based drug--drug interaction prediction. Bioinformatics. 2016;32:3175\u201382.","journal-title":"Bioinformatics"},{"key":"3644_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.drudis.2016.09.019","volume":"22","author":"Q Vanhaelen","year":"2017","unstructured":"Vanhaelen Q, Mamoshina P, Aliper AM, Artemov A, Lezhnina K, Ozerov I, et al. Design of efficient computational workflows for in silico drug repurposing. Drug Discov Today. 2017;22:210\u201322.","journal-title":"Drug Discov Today"},{"key":"3644_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1021\/ci500670q","volume":"55","author":"H Iwata","year":"2015","unstructured":"Iwata H, Sawada R, Mizutani S, Yamanishi Y. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data. J Chem Inf Model. 2015;55:446\u201359.","journal-title":"J Chem Inf Model"},{"key":"3644_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"F Cheng","year":"2018","unstructured":"Cheng F, Desai RJ, Handy DE, Wang R, Schneeweiss S, Barab\u00e1si A-L, et al. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun. 2018;9:1\u201312.","journal-title":"Nat Commun"},{"key":"3644_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"3644_CR28","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1039\/C7MB00400A","volume":"13","author":"H Motieghader","year":"2017","unstructured":"Motieghader H, Kouhsar M, Najafi A, Sadeghi B, Masoudi-Nejad A. mRNA--miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation. Mol BioSyst. 2017;13:2168\u201380.","journal-title":"Mol BioSyst"},{"key":"3644_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12859-018-2102-9","volume":"19","author":"J Peng","year":"2018","unstructured":"Peng J, Hui W, Shang X. Measuring phenotype-phenotype similarity through the interactome. BMC Bioinformatics. 2018;19:114.","journal-title":"BMC Bioinformatics"},{"key":"3644_CR30","doi-asserted-by":"publisher","first-page":"e1007384","DOI":"10.1371\/journal.pcbi.1007384","volume":"15","author":"N Franzese","year":"2019","unstructured":"Franzese N, Groce A, Murali TM, Ritz A. Hypergraph-based connectivity measures for signaling pathway topologies. PLoS Comput Biol. 2019;15:e1007384.","journal-title":"PLoS Comput Biol"},{"key":"3644_CR31","doi-asserted-by":"publisher","first-page":"e1004079","DOI":"10.1371\/journal.pcbi.1004079","volume":"11","author":"DA Weighill","year":"2015","unstructured":"Weighill DA, Jacobson DA. 3-way networks: application of hypergraphs for modelling increased complexity in comparative genomics. PLoS Comput Biol. 2015;11:e1004079.","journal-title":"PLoS Comput Biol"},{"key":"3644_CR32","first-page":"488","volume":"18","author":"H-T Yang","year":"2017","unstructured":"Yang H-T, Ju J-H, Wong Y-T, Shmulevich I, Chiang J-H. Literature-based discovery of new candidates for drug repurposing. Brief Bioinform. 2017;18:488\u201397.","journal-title":"Brief Bioinform"},{"key":"3644_CR33","first-page":"1664","volume":"4","author":"R Kaur","year":"2017","unstructured":"Kaur R, Gangwar R. A review on Naive Baye\u2019s (NB), J48 and K-means based mining algorithms for medical data mining. Int Res J Eng Technol. 2017;4:1664\u20138.","journal-title":"Int Res J Eng Technol"},{"key":"3644_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/bib\/bbv087","volume":"17","author":"GH Gonzalez","year":"2016","unstructured":"Gonzalez GH, Tahsin T, Goodale BC, Greene AC, Greene CS. Recent advances and emerging applications in text and data mining for biomedical discovery. Brief Bioinform. 2016;17:33\u201342.","journal-title":"Brief Bioinform"},{"key":"3644_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.artmed.2018.06.001","volume":"91","author":"S Hela","year":"2018","unstructured":"Hela S, Amel B, Badran R. Early anomaly detection in smart home: a causal association rule-based approach. Artif Intell Med. 2018;91:57\u201371.","journal-title":"Artif Intell Med"},{"key":"3644_CR36","doi-asserted-by":"crossref","unstructured":"Ezzat A, Wu M, Li X, Kwoh C-K. Computational prediction of drug-target interactions via ensemble learning. In: Computational methods for drug repurposing. New York, NY: Humana Press; 2019. p. 239\u201354.","DOI":"10.1007\/978-1-4939-8955-3_14"},{"key":"3644_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/1389203720666190123164310","volume":"20","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Yu H, Ji M, Zhao Y, Chen X. Computational model development of drug-target interaction prediction: a review. Curr Protein Pept Sci. 2019;20:492\u20134.","journal-title":"Curr Protein Pept Sci"},{"key":"3644_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12859-019-2644-5","volume":"20","author":"G Wu","year":"2019","unstructured":"Wu G, Liu J, Yue X. Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition. BMC Bioinformatics. 2019;20:134.","journal-title":"BMC Bioinformatics"},{"key":"3644_CR39","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.drudis.2017.03.009","volume":"22","author":"N Dovrolis","year":"2017","unstructured":"Dovrolis N, Kolios G, Spyrou G, Maroulakou I. Laying in silico pipelines for drug repositioning: a paradigm in ensemble analysis for neurodegenerative diseases. Drug Discov Today. 2017;22:805\u201313.","journal-title":"Drug Discov Today"},{"key":"3644_CR40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12859-019-2754-0","volume":"20","author":"Y Masoudi-Sobhanzadeh","year":"2019","unstructured":"Masoudi-Sobhanzadeh Y, Motieghader H, Masoudi-Nejad A. FeatureSelect: a software for feature selection based on machine learning approaches. BMC Bioinformatics. 2019;20:170.","journal-title":"BMC Bioinformatics"},{"key":"3644_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-44944-3","volume":"9","author":"M Kouhsar","year":"2019","unstructured":"Kouhsar M, Jamalkandi SA, Moeini A, Masoudi-Nejad A. Detection of novel biomarkers for early detection of non-muscle-invasive bladder cancer using competing endogenous RNA network analysis. Sci Rep. 2019;9:1\u201315.","journal-title":"Sci Rep"},{"key":"3644_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.eswa.2017.06.007","volume":"87","author":"AE-S Ezugwu","year":"2017","unstructured":"Ezugwu AE-S, Adewumi AO. Discrete symbiotic organisms search algorithm for travelling salesman problem. Expert Syst Appl. 2017;87:70\u20138.","journal-title":"Expert Syst Appl"},{"key":"3644_CR43","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1016\/j.eswa.2014.05.009","volume":"41","author":"M Ghaemi","year":"2014","unstructured":"Ghaemi M, Feizi-Derakhshi M-R. Forest optimization algorithm. Expert Syst Appl. 2014;41:6676\u201387.","journal-title":"Expert Syst Appl"},{"key":"3644_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.imu.2016.06.002","volume":"3","author":"Y Masoudi-Sobhanzadeh","year":"2016","unstructured":"Masoudi-Sobhanzadeh Y, Motieghader H. World Competitive Contests (WCC) algorithm: a novel intelligent optimization algorithm for biological and non-biological problems. Informatics Med Unlocked. 2016;3:15\u201328.","journal-title":"Informatics Med Unlocked"},{"key":"3644_CR45","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1016\/j.asoc.2011.05.008","volume":"11","author":"R Rajabioun","year":"2011","unstructured":"Rajabioun R. Cuckoo optimization algorithm. Appl Soft Comput. 2011;11:5508\u201318.","journal-title":"Appl Soft Comput"},{"key":"3644_CR46","doi-asserted-by":"publisher","first-page":"105991","DOI":"10.1016\/j.asoc.2019.105991","volume":"87","author":"Y Abdi","year":"2020","unstructured":"Abdi Y, Feizi-Derakhshi M-R. Hybrid multi-objective evolutionary algorithm based on search manager framework for big data optimization problems. Appl Soft Comput. 2020;87:105991.","journal-title":"Appl Soft Comput"},{"key":"3644_CR47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/math7090824","volume":"7","author":"M \u010crepin\u0161ek","year":"2019","unstructured":"\u010crepin\u0161ek M, Ravber M, Mernik M, Kosar T. Tuning multi-objective evolutionary algorithms on different sized problem sets. Mathematics. 2019;7:824.","journal-title":"Mathematics"},{"key":"3644_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-41728-7","volume":"9","author":"F Khalvati","year":"2019","unstructured":"Khalvati F, Zhang Y, Baig S, Lobo-Mueller EM, Karanicolas P, Gallinger S, et al. Prognostic value of CT radiomic features in resectable pancreatic ductal adenocarcinoma. Sci Rep. 2019;9:1\u20139.","journal-title":"Sci Rep"},{"key":"3644_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11906-018-0890-y","volume":"20","author":"J Davis","year":"2018","unstructured":"Davis J, Oparil S. Novel medical treatments for hypertension and related comorbidities. Curr Hypertens Rep. 2018;20:90.","journal-title":"Curr Hypertens Rep"},{"key":"3644_CR50","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s40267-017-0420-z","volume":"33","author":"dtp@adis.com AMW","year":"2017","unstructured":"dtp@adis.com AMW. Pharmacological management of stable angina pectoris aims to relieve symptoms and maximize survival. Drugs Ther Perspect. 2017;33:375\u201381.","journal-title":"Drugs Ther Perspect"},{"key":"3644_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pcad.2016.10.005","volume":"59","author":"WH Frishman","year":"2016","unstructured":"Frishman WH. Beta-adrenergic receptor blockers in hypertension: alive and well. Prog Cardiovasc Dis. 2016;59:247\u201352.","journal-title":"Prog Cardiovasc Dis"},{"key":"3644_CR52","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s00467-018-4092-2","volume":"34","author":"T Seeman","year":"2019","unstructured":"Seeman T, Hamdani G, Mitsnefes M. Hypertensive crisis in children and adolescents. Pediatr Nephrol. 2019;34:2523\u201337.","journal-title":"Pediatr Nephrol"},{"key":"3644_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40256-018-00316-2","volume":"19","author":"A Braschi","year":"2019","unstructured":"Braschi A. Potential protective role of blood pressure-lowering drugs on the balance between hemostasis and fibrinolysis in hypertensive patients at rest and during exercise. Am J Cardiovasc Drugs. 2019;19:133\u201371.","journal-title":"Am J Cardiovasc Drugs"},{"key":"3644_CR54","doi-asserted-by":"crossref","unstructured":"Wang X. Therapeutic effect of nifedipine combined with enalapril on elderly patients with coronary heart disease complicated with hypertension. J Clin Nurs Res. 2018;2.","DOI":"10.26689\/jcnr.v2i6.671"},{"key":"3644_CR55","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.mpmed.2018.06.014","volume":"46","author":"JR Waller","year":"2018","unstructured":"Waller JR, Waller DG. Drugs for systemic hypertension and angina. Medicine (Baltimore). 2018;46:566\u201372.","journal-title":"Medicine (Baltimore)"},{"key":"3644_CR56","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.pharep.2019.06.013","volume":"71","author":"B Quintana-Villamandos","year":"2019","unstructured":"Quintana-Villamandos B, Delgado-Martos MJ, Delgado-Baeza E. Early reversal cardiac with esmolol in hypertensive rats: the role of subcellular organelle phenotype. Pharmacol Rep. 2019;71:1125\u201332.","journal-title":"Pharmacol Rep"},{"key":"3644_CR57","first-page":"1","volume":"8","author":"Y Ji","year":"2018","unstructured":"Ji Y, Chen S, Wang Q, Xiang B, Xu Z, Zhong L, et al. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management. Sci Rep. 2018;8:1\u20137.","journal-title":"Sci Rep"},{"key":"3644_CR58","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074\u201382.","journal-title":"Nucleic Acids Res"},{"key":"3644_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuro.2018.11.003","volume":"70","author":"F Garc\u00eda-Alvarado","year":"2019","unstructured":"Garc\u00eda-Alvarado F, Govoni G, de Pascual R, Ruiz-Ruiz C, Mu\u00f1oz-Montero A, Gand\u00eda L, et al. Otilonium and pinaverium trigger mitochondrial-mediated apoptosis in rat embryo cortical neurons in vitro. Neurotoxicology. 2019;70:99\u2013111.","journal-title":"Neurotoxicology"},{"key":"3644_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(16)30274-2","volume":"17","author":"MJ Boeree","year":"2017","unstructured":"Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, et al. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Lancet Infect Dis. 2017;17:39\u201349.","journal-title":"Lancet Infect Dis"},{"key":"3644_CR61","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.drudis.2017.11.002","volume":"23","author":"RE Pogue","year":"2018","unstructured":"Pogue RE, Cavalcanti DP, Shanker S, Andrade RV, Aguiar LR, de Carvalho JL, et al. Rare genetic diseases: update on diagnosis, treatment and online resources. Drug Discov Today. 2018;23:187\u201395.","journal-title":"Drug Discov Today"},{"key":"3644_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00417-019-04523-8","volume":"258","author":"BB Rai","year":"2020","unstructured":"Rai BB, Sabeti F, Carle CF, Rohan EMF, Sara\u00e7 \u00d6, Van Kleef J, et al. Recovery dynamics of multifocal pupillographic objective perimetry from tropicamide dilation. Graefes Arch Clin Exp Ophthalmol. 2020;258:191\u2013200.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3644_CR63","first-page":"120","volume":"6","author":"Y Azuamah","year":"2019","unstructured":"Azuamah Y, Esenwah E, Ikoro N, Megwas A, Ugwuoke G, Ogbonna U. Effect of topical 1\\% Pilocarpine on the ocular tear film pH. Int J Res. 2019;6:120\u20138.","journal-title":"Int J Res"},{"key":"3644_CR64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.21088\/ijaa.2349.8471.5218.20","volume":"5","author":"S Ambasta","year":"2018","unstructured":"Ambasta S, Mahapatra S. Attenuation of hypertensive response with esmolol and labetalol in low doses in orotracheal intubation: a comparative study. Indian J Clin Anaesth. 2018;5:272\u20136.","journal-title":"Indian J Clin Anaesth"},{"key":"3644_CR65","doi-asserted-by":"publisher","first-page":"e0195047","DOI":"10.1371\/journal.pone.0195047","volume":"13","author":"AK Alencar","year":"2018","unstructured":"Alencar AK, Carvalho FI, Silva AM, Martinez ST, Calasans-Maia JA, Fraga CM, et al. Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats. PLoS One. 2018;13:e0195047.","journal-title":"PLoS One"},{"key":"3644_CR66","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.compbiomed.2019.05.006","volume":"109","author":"Y Masoudi-Sobhanzadeh","year":"2019","unstructured":"Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M, Masoudi-Nejad A. DrugR+: a comprehensive relational database for drug repurposing, combination therapy, and replacement therapy. Comput Biol Med. 2019;109:254\u201362.","journal-title":"Comput Biol Med"},{"issue":"suppl_1","key":"3644_CR67","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008;36(suppl_1):D901\u20136.","journal-title":"Nucleic Acids Res"},{"key":"3644_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"3644_CR69","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ygeno.2019.06.021","volume":"112","author":"Y Masoudi-Sobhanzadeh","year":"2020","unstructured":"Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M, Masoudi-Nejad A. Drug databases and their contributions to drug repurposing. Genomics. 2020;112:1087\u201395.","journal-title":"Genomics"},{"key":"3644_CR70","first-page":"1","volume":"8","author":"R Sawada","year":"2018","unstructured":"Sawada R, Iwata M, Tabei Y, Yamato H, Yamanishi Y. Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures. Sci Rep. 2018;8:1\u20139.","journal-title":"Sci Rep"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-03644-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-020-03644-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-03644-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T15:06:04Z","timestamp":1650207964000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-020-03644-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3644"],"URL":"https:\/\/doi.org\/10.1186\/s12859-020-03644-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-25124\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-22877\/v1","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"313"}}